Overcoming Economic Barriers To The Optimal Use Of Vaccines
- 1 May 2005
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 24 (3) , 666-679
- https://doi.org/10.1377/hlthaff.24.3.666
Abstract
Vaccines are among the most cost-effective interventions in health care, but economic factors may interfere with their optimal development and delivery in both industrialized and developing countries. For the United States, making the best use of available vaccines will require increasing the financing for vaccines via the public and private systems. For developing countries, innovative and promising approaches include pull mechanisms to establish predictable demand and push mechanisms such as targeted development programs. Partnerships between philanthropy and public resources have made progress in addressing gaps in vaccine financing and development for developing countries, but much remains to be done.Keywords
This publication has 15 references indexed in Scilit:
- Estimating medical practice expenses from administering adult influenza vaccinationsVaccine, 2005
- Global perspectives on vaccine financingExpert Review of Vaccines, 2004
- The Cost of Giving Childhood Vaccinations: Differences Among Provider TypesPediatrics, 2004
- Financing Immunizations in the United StatesClinical Infectious Diseases, 2004
- Preferences and Willingness to Pay for Health States Prevented by Pneumococcal Conjugate VaccinePediatrics, 2004
- Use of Quality Adjusted Life Years and Life Years Gained as Benchmarks in Economic Evaluations: A Critical AppraisalHealth Care Management Science, 2004
- The Intangible Value of VaccinationScience, 2002
- Understanding DALYsJournal of Health Economics, 1997
- Utilities and Quality-Adjusted Life YearsInternational Journal of Technology Assessment in Health Care, 1989
- Use and Misuse of the Term “Cost Effective” in MedicineNew England Journal of Medicine, 1986